Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study - Overman, M J; McDermott, R; Leach, J L (Lancet Oncol, 2017)